AMSTERDAM: Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks.
While the regulator said it considers the vaccine safe, it was up to the European Union's member states to decide how to use it, taking a similar stance to that with AstraZeneca. The EMA examined eight cases of clotting that occurred in US adults under 60 years, mostly women, within three weeks of vaccination with J&J's single shot. The cases were reported out of more than 7 million doses administered in the United States as of Apr 13.If treated early, health care professionals can help people in their recovery and avoid further complications, Sabine Straus, chair of EMA's safety committee, told the briefing.
"One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin," the EMA said.There have been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of all COVID-19 vaccines, it added.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »